Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
Polaryx Therapeutics, Inc. Common Stock
Market Cap
$104.67M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.72M
EBITDA Margin
6.31%
TTM Avg
-127.53%
3Y Avg
-89.97%
5Y Avg
-50.55%
Market Cap
$104.29M
EBITDA Margin
28.85%
TTM Avg
28.85%
3Y Avg
28.85%
5Y Avg
28.85%
Market Cap
$105.63M
EBITDA Margin
5.60%
TTM Avg
2.28%
3Y Avg
0.00%
5Y Avg
-2.15%
Market Cap
$109.09M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$105.79M
EBITDA Margin
-6164.17%
TTM Avg
-4620.17%
3Y Avg
-2654.54%
5Y Avg
-2163.85%
Market Cap
$102.40M
EBITDA Margin
-5221.43%
TTM Avg
-5221.43%
3Y Avg
-3887.65%
5Y Avg
-3386.47%
Market Cap
$106.66M
EBITDA Margin
-624817.90%
TTM Avg
-624817.90%
3Y Avg
-624817.90%
5Y Avg
-624817.90%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Polaryx Therapeutics, Inc. Common Stock (PLYX) | $104.67M | N/A | N/A | N/A | N/A |
| Definitive Healthcare Corp. (DH)vs › | $104.72M | 6.31% | -127.53% | -89.97% | -50.55% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $104.29M | 28.85% | 28.85% | 28.85% | 28.85% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $105.63M | 5.60% | 2.28% | 0.00% | -2.15% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $109.09M | N/A | N/A | N/A | N/A |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $105.79M | -6164.17% | -4620.17% | -2654.54% | -2163.85% |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.40M | -5221.43% | -5221.43% | -3887.65% | -3386.47% |
| Immunic, Inc. (IMUX)vs › | $106.66M | -624817.90% | -624817.90% | -624817.90% | -624817.90% |
| The Joint Corp. (JYNT)vs › | $102.21M | 1.47% | 3.45% | 8.31% | 9.97% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $107.41M | -4735.97% | -4735.97% | -4735.97% | -4735.97% |
Gross Margin
0.0%
EBITDA Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
